Los Angeles Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $169M | Buy |
|
|||||
|
2025
Q2 | $93.6M | Buy |
|
|||||
|
2025
Q1 | $421K | Sell |
|
|||||
|
2024
Q4 | $70M | Buy |
|
|||||
|
2024
Q3 | $48.5M | Buy |
|
|||||
|
2024
Q2 | $7.83M | Sell |
|
|||||
|
2024
Q1 | $33.8M | Sell |
|
|||||
|
2023
Q4 | $121M | Buy |
|
|||||
|
2023
Q3 | $62.3M | Buy |
|
|||||
|
2023
Q2 | $51.9M | Sell |
|
|||||
|
2023
Q1 | $64.3M | Sell |
|
|||||
|
2022
Q4 | $91.2M | Sell |
|
|||||
|
2022
Q3 | $84.1M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.34M | Sell |
|
|||||
|
2021
Q2 | $1.87M | Sell |
|
|||||
|
2021
Q1 | $5.39M | Sell |
|
|||||
|
2020
Q4 | $14M | Sell |
|
|||||
|
2020
Q3 | $17M | Buy |
|
|||||
|
2020
Q2 | $16.2M | Buy |
|
|||||
|
2020
Q1 | $926K | Buy |
|
|||||
|
2019
Q4 | $892K | Buy |
|
|||||
|
2019
Q3 | $322K | Sell |
|
|||||
|
2019
Q2 | $1.52M | Sell |
|
|||||
|
2019
Q1 | $2.2M | Buy |
|
|||||
|
2018
Q4 | $283K | Buy |
|
|||||
|
2018
Q3 | $257K | Sell |
|
|||||
|
2018
Q2 | $556K | Sell |
|
|||||
|
2018
Q1 | $669K | Buy |
|